The MAGEC3 Antibody (PAC010343) is a high-quality monoclonal antibody designed for research involving MAGEC3, a Cancer-Testis Antigen (CTA) that is commonly expressed in various types of cancer. This antibody, raised in mice, is specifically reactive with human MAGEC3 and has been validated for use in immunohistochemistry (IHC) applications. It targets the MAGEC3 protein, allowing for detection and analysis in tumor tissue samples, making it an essential tool for studies in oncology and cancer biology.
MAGEC3 is a promising target for cancer research due to its restricted expression in cancer cells and its potential role in driving tumorigenesis. Its overexpression in various cancer types, such as lung cancer and breast cancer, makes it a potential marker for diagnosis and a target for therapeutic intervention. Understanding the function and regulation of MAGEC3 is crucial for the development of targeted therapies and personalized treatment strategies in cancer patients.
